All stock lists
Unlock the score
Sensus Healthcare, Inc. (NASDAQ:SRTS)
US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
2.82-0.13 (-4.41%)
Market cap
$46.4M
Insider Score
Analyst consensus
Listed since
Jul 26, 2016
Website
Insider Score
/ 100
SRTS Insider Score
Sensus Healthcare, Inc. has a live Insider Score.
Scored on 8 qualifying trades from 2 insiders in the last 90 days.
SRTS Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 2.29 M | 3.39 M | 4.94 M | 6.88 M | 7.32 M | 8.34 M |
| Revenue Growth (YoY) | -68.69 % | -59.32 % | -62.20 % | -22.12 % | -20.82 % | -21.75 % |
| Cost of Revenue | 1.52 M | 2.40 M | 3.04 M | 4.17 M | 4.41 M | 3.99 M |
| Gross Profit | 769.00 K | 991.00 K | 1.90 M | 2.71 M | 2.90 M | 4.35 M |
| SG&A Expense | 2.84 M | 3.76 M | 3.17 M | 3.46 M | 3.38 M | 4.39 M |
| R&D Expense | 1.11 M | 1.59 M | 1.88 M | 1.82 M | 1.47 M | 2.61 M |
| Operating Expenses | 3.95 M | 5.35 M | 5.05 M | 5.28 M | 4.85 M | 7.00 M |
| Operating Income | -3.18 M | -4.36 M | -3.15 M | -2.57 M | -1.94 M | -2.65 M |
| Pretax Income | -3.06 M | -4.23 M | -2.99 M | -2.41 M | -1.76 M | -2.46 M |
| Tax Provision | 5.69 M | -1.61 M | 174.00 K | -1.47 M | -723.00 K | 110.00 K |
| Net Income | -8.75 M | -2.63 M | -3.17 M | -943.00 K | -1.04 M | -2.57 M |
| EPS (Basic) | -0.53 | -0.16 | -0.19 | -0.06 | -0.06 | -0.16 |
| EPS (Diluted) | -0.53 | -0.16 | -0.19 | -0.06 | -0.06 | -0.16 |
| Shares Outstanding | 16.46 M | 16.46 M | 16.33 M | 16.33 M | 16.32 M | 16.31 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
